Systemic Lupus Erythematosus SLE Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Corticosteroids, Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Anti-Inflammatories, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Antimalarials, BLyS-Specific Inhibitors or Monoclonal Antibodies (MAbS), Immunosuppressive Agents/Immune Modulators, Anticoagulants), By Application (Intravenous, Sub-Cutaneous, Oral, Topical), Regional Insights and Forecast to 2035